JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB227637

Anti-Met (c-Met) antibody [SP44] - C-terminal

Anti-Met (c-Met) 항체 [SP44] - C-terminal

5

(1 리뷰)

|

(15 제품이 사용된 논문 )

Anti-Met (c-Met) antibody [SP44] - C-terminal (ab227637) is a rabbit monoclonal antibody detecting Met (c-Met) in Flow Cytometry (Intra), IHC-P. Suitable for Human.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 10 publications
9 이미지
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)

Formalin-fixed, paraffin-embedded human colon adenocarcinoma tissue stained for Met (c-Met) using ab227637 at 1/50 dilution in immunohistochemical analysis.

Flow Cytometry (Intracellular) - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)

Flow cytometry overlay histogram showing wild-type HAP1 (green line) and MET knockout HAP1 cells stained with ab227637 (red line). The cells were fixed with 4% formaldehyde (10 min) and then permeabilized with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab227637) (1x106 in 100 μl at 0.04 μg/ml) for 30 min at 22°C.

The secondary antibody Goat anti-rabbit IgG H&L (Alexa Fluor® 488, pre-adsorbed) (ab150081) was used at 1/2000 for 30 min at 22°C.

Isotype control antibody was Rabbit IgG (monoclonal) (ab172730) used at the same concentration and conditions as the primary antibody (wild-type HAP1 - black line MET knockout HAP1 - grey line). Unlabelled sample was also used as a control (this line is not shown for the purpose of simplicity).

Acquisition of >5000 events were collected using a .

Flow Cytometry (Intracellular) - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)

Flow cytometric analysis of HT-29 (Human colorectal adenocarcinoma cell line) cell line labeling Met (c-Met) with ab227637 at 1/100 dilution (green) compared with a negative control of rabbit IgG (blue).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human colon carcinoma tissue sections labeling Met (c-Met) with ab227637 at 1/50 dilution (4.52 µg/ml). Heat mediated antigen retrieval was performed Heat mediated antigen retrieval with sodium citrate buffer (pH 6.0, epitope retrieval solution 1) for 10 mins. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.

Flow Cytometry (Intracellular) - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)

Flow Cytometry analysis of HepG2 (Human liver hepatocellular carcinoma cell line) cells labeling Met (c-Met) with purified ab227637 at 1/20 dilution (11.3 μg/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (ab172730) / Black. Unlabeled control - Unlabelled cells / blue.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)

Immunohistochemical analysis of paraffin-embedded HeLa wt cell pellet and HeLa MET KO cell pellet labeling MET (c-MET) with ab227637 at 1/50 dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining in human HeLa wt and negative staining in human HeLa MET KO cells. The section was incubated with ab227637 for 15 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Heat mediated antigen retrieval was performed with Citrate buffer (pH 6.0, Epitope Retrieval Solution 1) for 20 mins

Western blot - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)
  • WB

Lab

Western blot - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

The β chain undergoes degradation, resulting in lower molecular weight fragments (PMID : 32522525). To minimize protein degradation, cells/tissues were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting right away.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000000 dilution.

All lanes:

Western blot - Anti-Met (c-Met) antibody [SP44] - C-terminal (ab227637) at 1/1000 dilution

Lane 1:

Fresh HeLa cell lysate at 20 µg

Lane 2:

Frozen HeLa cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 145-175 kDa,35-55 kDa

false

Exposure time: 60s

Western blot - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)
  • WB

Lab

Western blot - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

c-Met can undergo glycosylation, resulting in a higher molecular weight. It can also be cleaved into α and β chains (PMID : 34210960). The β chain undergoes degradation, resulting in lower molecular weight fragments (PMID : 32522525). This antibody detects both the full-length c-Met and the β chains.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000000 dilution.

All lanes:

Western blot - Anti-Met (c-Met) antibody [SP44] - C-terminal (ab227637) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

MET knockout HeLa cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 145-175 kDa,35-55 kDa

false

Exposure time: 60s

Western blot - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)
  • WB

Lab

Western blot - Anti-Met (c-Met) antibody [SP44] - C-terminal (AB227637)

Blocking and diluting buffer and concentration : 5% NFDM /TBST

c-Met can undergo glycosylation, resulting in a higher molecular weight. It can also be cleaved into α and β chains (PMID : 34210960).
The β chain undergoes degradation, resulting in lower molecular weight fragments (PMID : 32522525).

ab227637 detects both the full-length c-Met and the β-chain, including β-chain degradation products between 35-55 kDa, and generally produces cleaner Western blot results than ab216574.

Lanes 1 - 2:

Western blot - Anti-Met (c-Met) antibody [SP44] - C-terminal (ab227637) at 1/1000 dilution

Lanes 3 - 4:

Western blot - Anti-Met (c-Met) antibody [EPR19067] (<a href='/ko/products/primary-antibodies/met-c-met-antibody-epr19067-ab216574'>ab216574</a>) at 1/1000 dilution

Lanes 1 and 3:

Wild-type HeLa cell lysate at 20 µg

Lanes 2 and 4:

MET knockout HeLa cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 145-175 kDa,35-55 kDa

false

Exposure time: 60s

관련 conjugated 항체와 다양한 조성의 항체 (7)

  • Carrier free

    Anti-Met (c-Met) antibody [SP44] - BSA and Azide free

  • 660 APC

    APC Anti-Met (c-Met) antibody [SP44] - C-terminal

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Met (c-Met) - C-terminal antibody [SP44]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-Met (c-Met) antibody [SP44] - C-terminal

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Met (c-Met) antibody [SP44] - C-terminal

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-Met (c-Met) antibody [SP44] - C-terminal

  • 578 PE

    PE Anti-Met (c-Met) antibody [SP44] - C-terminal

주요 정보

Host species

Rabbit

Clonality

Monoclonal

Clone number

SP44

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

Flow Cyt (Intra), WB, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50", "IHCP-species-notes": "<p>Primary antibody incubation for 30 minutes at room temperature.</p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/20 - 1/100", "FlowCytIntra-species-notes": "<p>Primary antibody incubation for 30 minutes at 4°C.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

제품 세부 정보

What is this antibody validated in?
Anti-Met (c-Met) antibody [SP44] - C-terminal (ab227637) is a rabbit recombinant monoclonal antibody and is validated for use in Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P) in Human samples.

Collaboration
Anti-Met (c-Met) [SP44] - C-terminal (ab227637) is a clone from the portfolio of Spring Bioscience (Roche) SP clones which have been optimised for immunohistochemistry (IHC).

Trusted by the scientific community
Anti-Met (c-Met) [SP44] - C-terminal (ab227637) was first used in a scientific publication in 2018 and has been cited over 10 times in peer-reviewed journals.

Specificity confirmed
The specificity of Anti-Met (c-Met) antibody [SP44] - C-terminal (ab227637) has been confirmed by Flow Cytometry testing in MET Knockout HAP1 cells.

Other related products
We have a range of other formats of antibody clone [SP44] also available for your convenience: ab227637, Carrier free - ab243930, APC - ab310844, PE - ab310915, Alexa Fluor® 647 - ab311109, Alexa Fluor® 568 - ab313008, Alexa Fluor® 488 - ab314588, Alexa Fluor® 750 - ab321431

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Protein A/G
Purification 관련 사항
Purified from TCS by protein A/G.
보관 버퍼
pH: 7.6 Preservative: 0.1% Sodium azide Constituents: PBS, 1% BSA
배송 시 보관 조건
Conditional Ambient
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with the morphogenetic effects while PI3K/AKT coordinates prosurvival effects. During embryonic development, MET signaling plays a role in gastrulation, development and migration of neuronal precursors, angiogenesis and kidney formation. During skeletal muscle development, it is crucial for the migration of muscle progenitor cells and for the proliferation of secondary myoblasts (By similarity). In adults, participates in wound healing as well as organ regeneration and tissue remodeling. Also promotes differentiation and proliferation of hematopoietic cells. May regulate cortical bone osteogenesis (By similarity).. (Microbial infection) Acts as a receptor for Listeria monocytogenes internalin InlB, mediating entry of the pathogen into cells.
See full target information MET

대체 명칭 보기

Hepatocyte growth factor receptor, HGF receptor, HGF/SF receptor, Proto-oncogene c-Met, Scatter factor receptor, Tyrosine-protein kinase Met, SF receptor, MET

제품이 사용된 논문 (15)

Recent publications for all applications. Explore the 전체 목록and refine your search

Scientific reports 13:3943 PubMed36894581

2023

Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs.

Applications

Unspecified application

Species

Unspecified reactive species

Chang-Yao Chu,Chien-Yu Lin,Chien-Chung Lin,Chien-Feng Li,Shang-Yin Wu,Jeng-Shiuan Tsai,Szu-Chun Yang,Chian-Wei Chen,Chia-Yin Lin,Chao-Chun Chang,Yi-Ting Yen,Yau-Lin Tseng,Po-Lan Su,Wu-Chou Su

Clinical cancer research : an official journal of the American Association for Cancer Research 27:2100-2110 PubMed33451980

2021

A MET Targeting Antibody-Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Alex Cazes,Oscar Betancourt,Edgar Esparza,Evangeline S Mose,Dawn Jaquish,Eric Wong,Alexis A Wascher,Hervé Tiriac,Marco Gymnopoulos,Andrew M Lowy

Molecular oncology 14:54-68 PubMed31736230

2019

TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Marco Gymnopoulos,Oscar Betancourt,Vincent Blot,Ryo Fujita,Diana Galvan,Vincent Lieuw,Sophie Nguyen,Jeanette Snedden,Christine Stewart,Jose Villicana,Jon Wojciak,Eley Wong,Raul Pardo,Neki Patel,Francois D'Hooge,Balakumar Vijayakrishnan,Conor Barry,John A Hartley,Philip W Howard,Roland Newman,Julia Coronella

Neoplasia (New York, N.Y.) 20:838-847 PubMed30015159

2018

Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Chien-Hung Gow,Yi-Nan Liu,Huei-Ying Li,Min-Shu Hsieh,Shih-Han Chang,Sheng-Ching Luo,Tzu-Hsiu Tsai,Pei-Lung Chen,Meng-Feng Tsai,Jin-Yuan Shih

Pathology, research and practice 214:572-578 PubMed29580750

2018

Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study.

Applications

Unspecified application

Species

Unspecified reactive species

Nadezda P Velizheva,Markus P Rechsteiner,Nadejda Valtcheva,Sandra N Freiberger,Christine E Wong,Bart Vrugt,Qing Zhong,Ulrich Wagner,Holger Moch,Sven Hillinger,Isabelle Schmitt-Opitz,Alex Soltermann,Peter J Wild,Verena Tischler

The oncologist 23:814-821 PubMed29445030

2018

Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Guilherme Rabinowits,Cecilia Lezcano,Paul J Catalano,Patricia McHugh,Hailey Becker,Megan M Reilly,Julian Huang,Ayushi Tyagi,Manisha Thakuria,Scott C Bresler,Lynette M Sholl,Geoffrey I Shapiro,Robert Haddad,James A DeCaprio

The journal of pathology. Clinical research 2:210-222 PubMed27785366

2016

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.

Applications

Unspecified application

Species

Unspecified reactive species

Fangjin Huang,Zhaoxuan Ma,Sara Pollan,Xiaopu Yuan,Steven Swartwood,Arkadiusz Gertych,Maria Rodriguez,Jayati Mallick,Sanica Bhele,Maha Guindi,Deepti Dhall,Ann E Walts,Shikha Bose,Mariza de Peralta Venturina,Alberto M Marchevsky,Daniel J Luthringer,Stephan M Feller,Benjamin Berman,Michael R Freeman,W Gregory Alvord,George Vande Woude,Mahul B Amin,Beatrice S Knudsen

Journal of clinical oncology : official journal of 34:721-30 PubMed26729443

2016

MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression.

Applications

Unspecified application

Species

Unspecified reactive species

Mark M Awad,Geoffrey R Oxnard,David M Jackman,Daniel O Savukoski,Dimity Hall,Priyanka Shivdasani,Jennifer C Heng,Suzanne E Dahlberg,Pasi A Jänne,Suman Verma,James Christensen,Peter S Hammerman,Lynette M Sholl

Diagnostic pathology 10:130 PubMed26215852

2015

Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?

Applications

Unspecified application

Species

Unspecified reactive species

I Watermann,B Schmitt,F Stellmacher,J Müller,R Gaber,Ch Kugler,N Reinmuth,R M Huber,M Thomas,P Zabel,K F Rabe,D Jonigk,A Warth,E Vollmer,M Reck,T Goldmann

Investigational new drugs 33:1108-14 PubMed26123926

2015

Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Sara M Tolaney,Sally Tan,Hao Guo,William Barry,Eliezer Van Allen,Nikhil Wagle,Jane Brock,Katherine Larrabee,Cloud Paweletz,Elena Ivanova,Pasi Janne,Beth Overmoyer,John J Wright,Geoffrey I Shapiro,Eric P Winer,Ian E Krop
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com